• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Alteogen Licenses Hybrozyme To Biogen For Subcutaneous Biologics

    PR NEWSWIRE

    Alteogen Secures Exclusive License For Subcutaneous Dostarlimab

    PR NEWSWIRE

    Merck Gets EU Approval For First Subcutaneous Cancer Treatment,

    INDPHARMAPOST

    Alteogen Gets EU Approval for Aflibercept Biosimilar Eyluxvi

    PR NEWSWIRE

    CHMP Backs Alteogen’s Aflibercept Biosimilar EYLUXVI (ALT-L9)

    PR NEWSWIRE

    Daiichi Sankyo partners Alteogen on subcutaneous Enhertu News

    PHARMAPHORUM

    Sandoz, Alteogen sign license agreement for biosimilar products

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.